Cibc Private Wealth Group, LLC Repligen Corp Transaction History
Cibc Private Wealth Group, LLC
- $51.3 Billion
- Q1 2025
A detailed history of Cibc Private Wealth Group, LLC transactions in Repligen Corp stock. As of the latest transaction made, Cibc Private Wealth Group, LLC holds 85 shares of RGEN stock, worth $12,764. This represents 0.0% of its overall portfolio holdings.
Number of Shares
85
Previous 80
6.25%
Holding current value
$12,764
Previous $11,000
9.09%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding RGEN
# of Institutions
510Shares Held
58.4MCall Options Held
89.3KPut Options Held
679K-
Black Rock Inc. New York, NY7.57MShares$1.14 Billion0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD6.6MShares$992 Million0.09% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.08MShares$762 Million0.01% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct1.91MShares$287 Million0.53% of portfolio
-
State Street Corp Boston, MA1.62MShares$244 Million0.01% of portfolio
About REPLIGEN CORP
- Ticker RGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 55,491,200
- Market Cap $8.33B
- Description
- Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....